Skip to main content
syn
Daily Digest
Culture

FDA notice to actors over Vimal Elaichi ad

Published Sunday, August 16, 2026 · Updated August 17

Share on X

Narrative Spectrum

Convergent Narrative · 0
  • FDA Action and Legal Justification — 1 source

Media Analysis

AI synthesis

The Maharashtra Food and Drug Administration (FDA) has issued show-cause notices to actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their Vimal Elaichi advertisement. The FDA is concerned that the ad's brand identity is too similar to Vimal Pan Masala, which could mislead consumers and indirectly promote a prohibited product. The notices specify the legal violations and potential penalties.

What We Know — Key Points

  • The Maharashtra Food and Drug Administration (FDA) has issued a show-cause notice to actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff for their advertisement of Vimal Elaichi.
  • The FDA's concern is that the Vimal Elaichi advertisement uses the same brand identity as Vimal Pan Masala, potentially misleading consumers and indirectly promoting a prohibited product.
  • The notices detail specific sections and provisions of various acts and regulations that the advertisements are alleged to violate, outlining potential penalties and response procedures.

What Is Claimed — Perspectives

FDA Action and Legal Justification
  • The Hindu

    The Hindu reports that the Maharashtra FDA issued show-cause notices to actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their Vimal Elaichi advertisement, citing concerns that it uses the same brand identity as Vimal Pan Masala, potentially misleading consumers and indirectly promoting a prohibited product. The articles also explain the legal basis for the FDA's actions, detailing the specific violations of acts and regulations, and outlining potential penalties and response procedures.

AI-Generated Content

  • This topic was generated by an AI system.
  • Key points, perspectives, bias labels, and categorisation may contain errors.
  • This is not journalism. Do not rely on this content for critical decisions.
  • Read our full AI disclaimer for details.